Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema
Abstract Purpose Comparison of the efficacy of monthly anti-VEGF versus dexamethasone (DEX) implant in patients with diabetic macular edema (DME) whose macular edema persists despite three doses of anti-VEGF therapy. Materials and methods This retrospective study included 94 eyes of 94 patients with...
Main Authors: | Hakan Koc, Atilla Alpay, Suat Hayri Ugurbas |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-03-01
|
Series: | BMC Ophthalmology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12886-023-02831-6 |
Similar Items
-
Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema
by: Thomas BJ, et al.
Published: (2016-08-01) -
A Real-Life Study: Intravitreal Aflibercept, Ranibizumab and Dexamethasone for Macular Edema Secondary to Branch Retinal Vein Occlusion
by: Alper Halil Bayat, et al.
Published: (2019-12-01) -
Repeated Treatment for Macular Edema in Vein Occlusion by Intravitreal Implant of Dexamethasone
by: Frederic Matonti, et al.
Published: (2012-10-01) -
Intravitreal Dexamethasone Implant for the Treatment of Patient with Resistant to Anti-VEGF Diabetic Macular Edema
by: M. M. Bikbov, et al.
Published: (2020-08-01) -
Comparison of intravitreal ranibizumab monotherapy vs. ranibizumab combined with dexamethasone implant for macular edema secondary to retinal vein occlusion
by: Xuemei Liang, et al.
Published: (2022-09-01)